Back

Single-Cell Translation and Apoptosis Profiling to Define Human CD34⁺ Cell Response to Specific Factors

Li, D.; Gustafsson, K.; Milosevic, J.; Kiem, A.; Scadden, D. T.

2026-05-25 cell biology
10.64898/2026.05.21.726964 bioRxiv
Show abstract

Global mRNA translation is a defining functional property of hematopoietic stem cells (HSCs) and is increasingly recognized as a critical axis of dysregulation in myelodysplastic syndromes (MDS) and other clonal hematopoietic disorders. Yet the quantitative measurement of protein synthesis at single-cell resolution across phenotypically defined HSPC subpopulations, in parallel with apoptotic state, is technically challenging. Here we describe and validate a single-tube flow cytometry protocol that simultaneously quantifies global protein synthesis by O-propargyl-puromycin (OP-Puro) incorporation and intracellular cleaved Caspase-3 with cell immunophenotyping across the canonical CD34+ HSPC hierarchy in cryopreserved human cord blood (CB) CD34+ cells. The protocol enables quantitative assessment of key dynamic cell processes in defined subsets of primary hematopoietic cells on a standard flow cytometer. We apply this assay to a four-condition factor-omission analysis of the canonical SR1 + UM729 + dmPGE2 ex vivo expansion cocktail across three independent CB donors. The analysis assigns each compound a distinct functional profile: UM729 constrains protein synthesis and supports apoptotic priming across the hierarchy; SR1 maintains a pro-survival state without modulating translation; and dmPGE2 promotes HSC cycling and progressive exit from the primitive state, with minimal direct effect on the translation or apoptotic axes measured here. This analysis resolves three mechanistically distinct small-molecule signatures using a protocol directly transferable to clinical biobank specimens. We propose it as a functional-state analytic platform that may be useful for patient-derived CD34+ cells from MDS and other myeloid neoplasms in which translational dysregulation is a recognized pathological feature.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Blood Advances
54 papers in training set
Top 0.1%
12.2%
2
Nature Communications
4913 papers in training set
Top 23%
8.3%
3
eLife
5422 papers in training set
Top 11%
6.7%
4
Cell Reports Methods
141 papers in training set
Top 0.4%
6.3%
5
Blood
67 papers in training set
Top 0.4%
4.3%
6
JCI Insight
241 papers in training set
Top 1%
3.9%
7
Haematologica
24 papers in training set
Top 0.1%
3.6%
8
Cell Reports Medicine
140 papers in training set
Top 1%
3.6%
9
Cell Reports
1338 papers in training set
Top 15%
3.6%
50% of probability mass above
10
Cytometry Part A
30 papers in training set
Top 0.1%
3.0%
11
Science Translational Medicine
111 papers in training set
Top 1%
2.6%
12
Nucleic Acids Research
1128 papers in training set
Top 9%
2.1%
13
iScience
1063 papers in training set
Top 12%
1.9%
14
Science Advances
1098 papers in training set
Top 16%
1.8%
15
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 33%
1.7%
16
PLOS ONE
4510 papers in training set
Top 56%
1.5%
17
Cell Systems
167 papers in training set
Top 9%
1.3%
18
Scientific Reports
3102 papers in training set
Top 64%
1.3%
19
Nature Medicine
117 papers in training set
Top 3%
1.3%
20
Communications Biology
886 papers in training set
Top 13%
1.3%
21
Cancer Discovery
61 papers in training set
Top 1%
1.3%
22
Developmental Cell
168 papers in training set
Top 10%
1.2%
23
Clinical Cancer Research
58 papers in training set
Top 1%
1.1%
24
Life Science Alliance
263 papers in training set
Top 0.9%
0.9%
25
Nature Cell Biology
99 papers in training set
Top 4%
0.9%
26
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.6%
0.9%
27
Stem Cell Reports
118 papers in training set
Top 0.9%
0.8%
28
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.8%
29
Cell Stem Cell
57 papers in training set
Top 2%
0.8%
30
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.7%